Last reviewed · How we verify
Glycerol
At a glance
| Generic name | Glycerol |
|---|---|
| Also known as | Control infusion, glycerol infusion, Glycerin(e), glycerol water mixture |
| Sponsor | Rutgers, The State University of New Jersey |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Constipation
Common side effects
- Diarrhea
- Flatulence
- Headache
- Abdominal pain
- Vomiting
- Decreased appetite
- Fatigue
- Dyspepsia
- Nausea
Key clinical trials
- Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia (NA)
- PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS) (PHASE2)
- Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy (NA)
- Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2) (PHASE1)
- Eschscholzia Study (PHASE3)
- Microbiome in Head and Neck Squamous Cell Carcinoma
- Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes (NA)
- A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus) (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |